EUVIMEDEUVIMED entdecken
Crossref

Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients

Ivana Djordjevic, Nemanja Garai, Stojan Peric, Jelena Karanovic, Jovan Pesovic, Milos Brkusanin, Dragana Lavrnic, Slobodan Apostolski, Dusanka Savic-Pavicevic, Ivana Basta

Molecular Neurobiology · 2024

DOI: 10.1007/s12035-024-04183-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Neurobiology, 2024. Verfasst von Ivana Djordjevic und 9 weiteren Autor:innen. Beteiligte Einrichtung: University Clinical Center of Serbia, Neurology Clinic, 6 Dr Subotića starijeg street, Belgrade, 11129, Serbia. icadejanovic@gmail.com. Hauptthemen laut MEDLINE: Myasthenia Gravis, CTLA-4 Antigen, Genetic Predisposition to Disease, Age of Onset. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Ministry of science, Technological Development and Innovations of the Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome-wide association studies (GWAS) have provided strong evidence that early- and late-onset MG have different genetic backgrounds. Recent in silico analysis based on GWAS results revealed rs231735 and rs231770 variants within CTLA-4 locus as possible MG causative genetic factors. We aimed to explore the association of rs231735 and rs231770 with MG in a representative cohort of Serbian patients. We conducted an age-, sex-, and ethnicity-matched case-control study. Using TaqMan allele discrimination assays, the frequency of rs231735 and rs231770 genetic variants was examined in 447 AChR-MG patients and 447 matched controls. There was no significant association of rs231735 and rs231770 with the entire MG cohort (P > 0.05). Nevertheless, when stratifying patients into early-onset (n = 183) and late-onset MG (n = 264), we found early-onset patients had a significantly lower frequency of the rs231735 allele T compared to controls (OR = 0.734, 95% CI = 0.575-0.938, p10e6 permutation < 0.05), and rs231735 genotype TT and rs231770 genotype TT had a protective effect on early-onset MG (OR = 0.548, 95% CI = 0.339-0.888, and OR = 0.563, 95% CI = 0.314-1.011, p10e6 permutation < 0.05). Consequently, we found that individuals with the rs231735-rs231770 haplotype GC had a higher risk for developing early-onset MG (OR = 1.360, P = 0.027, p10e6 permutation < 0.05). Our results suggest that CTLA-4 rs231735 and rs231770 may be risk factors only for patients with early-onset MG in Serbian population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisCTLA-4 AntigenGenetic Predisposition to DiseaseAge of OnsetPolymorphism, Single NucleotideReceptors, CholinergicHumansMaleFemaleSerbiaAdultCase-Control StudiesMiddle AgedGene FrequencyGenetic LociYoung AdultAged

Stichwörter der Autor:innen

Autoimmune diseaseCD152CTLA-4Myasthenia gravisSingle-nucleotide polymorphism

Substanzen

CTLA-4 AntigenReceptors, CholinergicCTLA4 protein, human

Autor:innen und Institutionen

  • University Clinical Center of Serbia, Neurology Clinic, 6 Dr Subotića starijeg street, Belgrade, 11129, Serbia. icadejanovic@gmail.com.
  • University of Belgrade, Faculty of Biology, Center for Human Molecular Genetics, Belgrade, Serbia.
  • University Clinical Center of Serbia, Neurology Clinic, 6 Dr Subotića starijeg street, Belgrade, 11129, Serbia.
  • University of Belgrade, Faculty of Medicine, Belgrade, Serbia.
  • University of Belgrade, Institute of Molecular Genetics and Genetic Engineering, Laboratory for Molecular Biology, Belgrade, Serbia.
  • Outpatient Neurological Clinic "Apostolski", Belgrade, Serbia.

Förderung

  • Ministry of science, Technological Development and Innovations of the Republic of Serbia

Zitieren

APA

Djordjevic, I., Garai, N., Peric, S., Karanovic, J., Pesovic, J., Brkusanin, M., Lavrnic, D., Apostolski, S., Savic-Pavicevic, D., & Basta, I. (2024). Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04183-8

Vancouver

Djordjevic I, Garai N, Peric S, Karanovic J, Pesovic J, Brkusanin M, et al. Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients. Molecular Neurobiology. 2024. doi:10.1007/s12035-024-04183-8

BibTeX
@article{Djordjevic2024,
  author = {Djordjevic, Ivana and Garai, Nemanja and Peric, Stojan and Karanovic, Jelena and Pesovic, Jovan and Brkusanin, Milos and Lavrnic, Dragana and Apostolski, Slobodan and Savic-Pavicevic, Dusanka and Basta, Ivana},
  title = {Association between Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4) Locus and Early-Onset Anti-acetylcholine Receptor-Positive Myasthenia Gravis in Serbian Patients},
  journal = {Molecular Neurobiology},
  year = {2024},
  doi = {10.1007/s12035-024-04183-8}
}
Kostenlos starten →